Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing two types of esophageal stents for treating swallowing difficulties in cancer patients

Official title: Comparative Study Between Fully Covered Esophageal Prosthesis (FC-SEMS) and Partially Covered Esophageal Prosthesis (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.

Run by Instituto do Cancer do Estado de São Paulo · NCT06070376 · Data updated 2026-11-12

This study is testing whether fully covered or partially covered esophageal stents can help cancer patients with swallowing difficulties feel better.

More Dysphagia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment34 (estimated)
SponsorInstituto do Cancer do Estado de São Paulo
Academic / other
Drugs / interventionschemotherapy
Locations1 site (São Paulo, São Paulo)
StatusRecruiting
StartedJune 26, 2023
Main results expectedFebruary 26, 2027
Study endsAugust 26, 2027
Registry record updatedJuly 17, 2026
Trial IDNCT06070376 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with advanced esophageal cancer experiencing severe swallowing difficulties.

Probably not a fit

Patients under 18 years or those with specific types of esophageal lesions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of fully covered esophageal stents (FC-SEMS) versus partially covered esophageal stents (PC-SEMS) in alleviating dysphagia caused by advanced esophageal cancer. Patients with significant swallowing difficulties will be randomly assigned to receive one of the two types of stents, and their outcomes will be monitored for the need for reinterventions and any adverse events. The placement of the stents will be performed under sedation or general anesthesia in an outpatient setting, ensuring patient safety and comfort. This prospective study aims to provide insights into the best palliative care options for patients suffering from esophageal neoplasms.

Why it matters

Potential benefit: If successful, this study could significantly improve the quality of life for patients suffering from dysphagia due to esophageal cancer.

How similar studies have gone: Previous studies have shown promising results with esophageal stenting for dysphagia, indicating that this approach is both viable and beneficial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with advanced malignant neoplasm of the esophagus, whether or not undergoing chemotherapy or radiotherapy;
* Dysphagia score greater than 2 or presence of malignant esophagorespiratory fistula;
* Indication of palliation of dysphagia through the placement of esophageal prostheses in a multidisciplinary meeting.

Exclusion Criteria:

* Patients under 18 years;
* Extraesophageal neoplasms;
* Lesions with longitudinal extension less than 30 mm;
* Previous treatment with esophageal prosthesis;
* Tumors easily transposed to standard endoscope (9.8mm).

Where it's running

  • Instituto do Câncer do Estado de São Paulo
    São Paulo, São Paulo, Brazil
    Recruiting

Study contacts

  • Principal investigator: Fauze Maluf-Filho, PhD — Cancer Institute of the state of São Paulo (ICESP)
  • Study coordinator: Fauze Maluf-Filho, PhD
  • Email: fauze.maluf@terra.com.br
  • Phone: +5511991919014

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.